Angiotensin converting enzyme inhibitors (ACEi) are efficient in reducing blood pressure (BP), proteinuria and risk of kidney disease progression in children with chronic kidney disease (CKD) [9,10]. The gene discussed is ACE; the disease is chronic kidney disease.